Metabolic syndrome in liver transplantation: A preoperative and postoperative concern
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Aug 2016 · 1 min read
In brief
In brief
This retrospective study of 114 liver transplant patients examines how preoperative metabolic syndrome factors affect post-transplant outcomes. Preoperative diabetes and obesity significantly predict new-onset metabolic syndrome after transplantation, which correlates with increased hospital readmissions in the first year.
Written by the GCMD Library team from the article.
Statements in this article
Nonalcoholic steatohepatitis is a manifestation of metabolic syndrome and is an increasingly common cause of end-stage liver disease necessitating orthotopic liver transplantation.
Patients with and without metabolic syndrome were similar with regard to age, race, and model for end-stage liver disease at time of transplant.
Preoperative diabetes was found to be associated with an increased rate of readmission with an odds ratio of 3.45.
Preoperative metabolic syndrome itself was not a significant predictor of worse outcomes.
Postoperative metabolic syndrome was associated with significantly greater readmissions in the first year.
Preoperative diabetes is a major predictor of new onset metabolic syndrome after orthotopic liver transplantation with an odds ratio of 8.54.
Preoperative obesity is a major predictor of new onset metabolic syndrome after orthotopic liver transplantation with an odds ratio of 5.49.
Efforts to decrease the incidence of postoperative metabolic syndrome after orthotopic liver transplantation may decrease readmissions and improve outcomes.